NRG-GY017

Study Title: 
Anti PD-L1 (Atezolizumab) as an Immune Primer and Concurrently with Extended Field Chemoradiotherapy for Node Positive Locally Advanced Cervical Cancer
Lead Group: 
Status: 
Review Status: